Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

88.42
Delayed Data
As of May 24
 +4.00 / +4.74%
Today’s Change
75.90
Today|||52-Week Range
143.45
-29.73%
Year-to-Date
A Heavy Hitter Just Stepped Up to the Cystic Fibrosis Plate
May 20 / MotleyFool.com - Paid Partner Content
5 Top Biotech Stocks to Buy on Sale
May 17 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Pfizer to Buy Anacor for $5.2B, Pipeline Setbacks for Aduro, T...
May 19 / Zacks.com - Paid Partner Content
Nivalis Starts Dosing in Second Phase II Cystic Fibrosis Study
May 17 / Zacks.com - Paid Partner Content
Carlson Reduces Holdings in Monsanto and eBay in st Quarter
May 18 / GuruFocus News - Paid Partner Content
Pioneer climbs on oil output optimism
Apr 26 / FT.com - Paid Partner Content